Catalyst Wire Dossier Catalyst Wire Dossier

PRO-155 ophthalmic solution 0.09%

· Laboratorios Sophia S.A de C.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PRO-155 ophthalmic solution 0.09%, covering 2019-07-19 to 2019-07-19. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of PRO-155 Ophthalmic Solution 0.09% in Healthy Volunteers. [Phase 1]

See pricing